Home  >  News
eppen_NEW-Himac_Jan_2026
you can get e-magazine links on WhatsApp. Click here
News
  Gradalis announces positive results from phase 2b VITAL trial of Vigil to treat patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer,   January 16, 2026
  GCCL and OPIS sign MoU to advance global clinical trial capabilities,   January 16, 2026
  Johnson & Johnson announces positive results from phase 3 MajesTEC-9 study of Tecvayli in patients with multiple myeloma,   January 16, 2026
  SafeHeal begins patient enrolment in SAFE-3CV IDE study for Colovac anastomosis protection technology,   January 15, 2026
  Boehringer Ingelheim begins phase IIa trial of BI 765423, a novel monoclonal antibody targeting IL-11, in patients with idiopathic pulmonary fibrosis,   January 15, 2026
  Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation,   January 15, 2026
  CARsgen and Dispatch Bio ink clinical collaboration to evaluate flare platform and zevor-cel in solid tumours,   January 14, 2026
  Boehringer Ingelheim enters clinical collaboration with Jazz Pharma to advance HER2-targeted therapy in breast cancer,   January 14, 2026
  NIH, Merck and Gates MRI completes phase I trial of TBD09/MK-7762 TB drug candidate,   January 14, 2026
  TROPION-Lung17 TROP2 biomarker directed phase 3 trial of Datroway initiated in patients with previously treated advanced nonsquamous NSCLC,   January 14, 2026
  Bristol Myers Squibb reports positive results from phase 3 SCOUT-HCM trial of Camzyos in adolescents with symptomatic oHCM,   January 14, 2026
  US FDA issues guidance on modernizing statistical methods for clinical trials,   January 14, 2026
  Clover Biopharmaceuticals begins phase 2 trial for RSV + hMPV ± PIV3 respiratory combination vaccine candidates,   January 13, 2026
  Phanes Therapeutics reports positive phase 2 results of spevatamig in combo with chemotherapy in frontline treatment of metastatic PDAC,   January 12, 2026
  GRIN Therapeutics begins patient dosing in global phase 3 Beeline trial of investigational radiprodil for GRINRelated neurodevelopmental disorder,   January 12, 2026
  4Moving Biotech receives US FDA’s IND clearance for 4P004; strengthens its position as a leading innovator in disease-modifying osteoarthritis therapeutics,   January 10, 2026
  MRM Health receives US FDA IND clearance to initiate phase 2b trial of MH002 in mild-to-moderate ulcerative colitis,   January 10, 2026
  NRG Therapeutics doses its first-in-human phase 1 trial for NRG5051 to treat ALS/MND and Parkinson’s disease,   January 10, 2026
  Merck begins phase 3 KANDLELIT-007 trial of calderasib in combo Keytruda QLEX in certain patients with advanced NSCLC,   January 09, 2026
  Sobi to advance Gamifant in interferon-gamma-driven sepsis based on EMBRACE topline data,   January 09, 2026

  • Results Found: 16760
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 838
 Back
 
ASIA_PHARMA_EXPO_2026
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram